Gilead Sciences reported $9.22B in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
ALKERMES ALKS:US $ 438.52M 23.84M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Coherus Biosciences CHRS:US $ 140.75M 12.99M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Glaxosmithkline GSK:US $ 37835M 13557M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Moderna Inc MRNA:US 6.81B 2.43B
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vertex Pharmaceuticals VRTX:US $ 2317.5M 137.3M
YTE INCY:US $ 926.67M 40.51M